T. Rowe Price Associates’s NxStage Medical Inc. NXTM Stock Holding History

T. Rowe Price Associates’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-19,576	Closed	-$560K	–	2589
2018 Q4	$560K	Buy	19,576 +108	+0.6%	+$3.07K	﹤0.01%	2030
2018 Q3	$543K	Sell	19,468 -121	-0.6%	-$3.4K	﹤0.01%	2124
2018 Q2	$547K	Buy	19,589 +5,397	+38%	+$145K	﹤0.01%	2096
2018 Q1	$353K	Buy	14,192 +127	+0.9%	+$3.09K	﹤0.01%	2222
2017 Q4	$341K	Buy	14,065 +5,780	+70%	+$152K	﹤0.01%	2236
2017 Q3	$229K	Hold	8,285	–	–	﹤0.01%	2368
2017 Q2	$208K	Buy	8,285 +10	+0.1%	+$248	﹤0.01%	2368
2017 Q1	$222K	Hold	8,275	–	–	﹤0.01%	2362
2016 Q4	$217K	Sell	8,275 -25	-0.3%	-$618	﹤0.01%	2362
2016 Q3	$207K	Buy	+8,300	New	+$194K	﹤0.01%	2345

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

T. Rowe Price Associates's NXTM Position: Q1 2019 in Review

T. Rowe Price Associates sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 19,576 shares — an estimated $560K sold.

T. Rowe Price Associates first reported a position in NXTM in Q3 2016 and held it in 10 quarters. The position peaked at $560K in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

T. Rowe Price Associates reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
T. Rowe Price Associates sold 19,576 NxStage Medical Inc. shares in Q1 2019, an estimated $560K.
T. Rowe Price Associates first reported a position in NxStage Medical Inc. in Q3 2016 and held it in 10 quarters.
T. Rowe Price Associates's NxStage Medical Inc. position peaked at $560K in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.